Exelon (rivastigmine) has been approved by the FDA for treating mild to moderate dementia associated with Parkinson's disease.

Management of Alzheimer's Disease and Related Dementias CME
This general overview of cholinesterase inhibitors discusses studies on using them to treat Parkinson's dementia. The Management of Alzheimer's Disease and Related Dementias: Part 2 -- The Role of
http://cme.medscape.com/viewarticle/467554_1
Rivastigmine May Relieve Neuropsychiatric Symptoms
Rivastigmine May Relieve Neuropsychiatric Symptoms in Patients With Parkinson's Disease Dementia: Presented at AAGP By Emma Hitt, PhD HONOLULU -- March 8, 2009 -- Rivastigmine appears to relieve
http://www.docguide.com/news/content.nsf/news/8525...